# Brent Dover

> Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.

- **Role:** CEO at Carta Healthcare
- **Organizations:** Carta Healthcare, Kalderos, Commure, Health Catalyst, Medicity
- **Nationality:** American
- **Education:** BS in Systems Engineering, University of Arizona
- **Known for:** Led Medicity to $500M acquisition by Aetna (2011), generating 16x investor returns, Served as President at Health Catalyst through its NASDAQ IPO (ticker: HCAT), Grew Commure to a $3.5 billion valuation as CEO

## Career timeline

- **1984-1988** — BS Systems Engineering, University of Arizona
- **2007-2012** — President at Medicity; led company to $500M acquisition by Aetna in 2011, generating 16x return for investors
- **2013-2018** — President at Health Catalyst; managed all client-facing operations through company's path to NASDAQ IPO (HCAT)
- **2019-2021** — CEO at Commure; grew healthcare developer platform to $3.5 billion valuation
- **2022-2023** — CEO at Kalderos; led drug discount platform focused on 340B program transparency
- **2023-present** — CEO at Carta Healthcare; succeeded co-founder Matt Hollingsworth; drove 2x revenue growth, Series B1 of $18.25M, and acquisition of Realyze Intelligence

## Achievements

- Led Medicity to $500M acquisition by Aetna (2011), generating 16x investor returns
- Served as President at Health Catalyst through its NASDAQ IPO (ticker: HCAT)
- Grew Commure to a $3.5 billion valuation as CEO
- Drove 2x revenue growth at Carta Healthcare in 2025
- Maintained 100% customer retention rate at Carta Healthcare
- Closed 25 new hospital customer contracts in 2025
- Secured $18.25M Series B1 funding led by UPMC Enterprises (May 2025)
- Led acquisition of Realyze Intelligence (December 2024), enabling 7x more patient-trial matches
- Carta Healthcare won 6 major industry awards in 2025, including Best Use of AI in Healthcare (Gold)

## Latest updates

- **2025-05** — Carta Healthcare secures $18.25M Series B1 funding led by UPMC Enterprises to accelerate AI-powered clinical data abstraction and analytics
- **2025-04** — Carta Healthcare achieves breakout growth: 2x revenue, 100% customer retention, 25 new contracts, 144 new hires, 6 industry awards
- **2024-12** — Carta Healthcare acquires Realyze Intelligence to power oncology research and clinical trial matching
- **2023-12** — Brent Dover named CEO of Carta Healthcare, succeeding co-founder Matt Hollingsworth

## Links

- Website: https://carta.healthcare
- LinkedIn: https://www.linkedin.com/in/brent-dover-403821

---

Profile page: https://yespress.io/brent-dover
Published by YesPress — https://yespress.io
Last updated: 2026-05-27